Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
about
Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDUse of animal models in elucidating disease pathogenesis in IBD.Experimental Models of Inflammatory Bowel Diseases.Genetic analysis of TNFST15 variants in ankylosing spondylitis.Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine ColitisTumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patients.The Role of Cytokines in the Fibrotic Responses in Crohn's Disease.Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.A role for bacterial urease in gut dysbiosis and Crohn's disease.Death Receptor 3 regulates distinct pathological attributes of acute versus chronic murine allergic lung inflammation.An anti-TL1A antibody for the treatment of asthma and inflammatory bowel disease.
P2860
Q26740540-AD41CC42-061C-4491-940F-224884A3EAFCQ34384544-E5300F8F-070F-4C18-B03A-C86AEAF205D2Q35618798-C8AB2BE8-D1B8-4EFE-92D3-5B40A1D7F4A4Q36464913-90D9916C-FC1F-41E5-AFD2-48B304B9E8B0Q36576498-AC99B7BD-7EFE-4D18-94D5-612868A3A463Q38534313-778E021C-0A3C-4A1A-952B-0AC441FFD723Q38748557-0FAB8001-F1E2-4647-B721-22813210889BQ38990222-C2DC44FF-0DC2-4049-9DC0-BD1841E12ACFQ40991575-74E9C464-4EC2-43D0-B134-89FFCB1375CEQ41273741-C23E5AA3-45F2-4822-8B9B-1A15566E3213Q45142042-9A5D7919-BB9C-46EF-BB8E-DF49C61C238BQ46260829-0CFA9F5A-2864-4797-B57B-2C1974AE1E33Q47106615-5752863A-4C25-46FD-A65C-317FAC134269Q50046700-464E2AE2-7D4E-4EB8-9E2E-D4834F9389F2
P2860
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@ast
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@en
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@nl
type
label
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@ast
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@en
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@nl
prefLabel
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@ast
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@en
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.
@en
P2093
C Pothoulakis
K L Wallace
R Ichikawa
S R Targan
P2860
P2888
P304
P356
10.1038/MI.2014.37
P577
2014-05-21T00:00:00Z
P5875
P6179
1043407330